FREEDOM251

Freedom251 › Systematic Review Software

RevMan

Free plan LinuxMacWebWindows

Visit RevMan Alternatives Pricing

RevMan's own site

What RevMan is

RevMan is Cochrane software for preparing systematic reviews, with tools for structured data entry, analysis, and presenting results. It supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. Authors can edit separate parts of a review at the same time and see who else is working on it. Analysis includes pairwise meta-analyses, sensitivity and subgroup analyses, and fixed-effects, random-effects, Mantel-Haenszel, and inverse-variance models. Built-in outputs include forest, SROC, and funnel plots, risk-of-bias assessments, and PRISMA flow diagrams. Writers can use ready-made or custom templates and structured headings with Cochrane methodological guidance. RevMan imports study data and references from Covidence; RIS reference files can use data from Crossref, PubMed, or CRS. The free Practice review is limited to one person and is deleted after 30 days, with no data export. Individual subscriptions are listed from £80/user/yr, with VAT applying in the EU and UK. Mobile devices and touchscreen use are not supported.

Who it suits

RevMan suits authors producing systematic reviews, including diagnostic accuracy, intervention, prognosis, qualitative, and other listed review types. It can also suit teams that need to edit different sections concurrently.

What it does well

  • Supports multiple systematic review types.
  • Authors can edit a review simultaneously.
  • Offers several meta-analysis models and subgroup analyses.
  • Creates plots, risk-of-bias assessments, and PRISMA diagrams.
  • Imports study data and references from Covidence.

What to know first

  • Practice reviews are deleted after 30 days.
  • Practice reviews have no data export.
  • Mobile and touchscreen use are unsupported.
  • GRADEpro integration is unavailable for non-Cochrane reviews.

Limits

The free practice review is deleted after 30 days, has no data export, and allows one person per review. Paid subscribers can access reviews and their history for 60 days after a subscription ends.

Plans

PlanBilled and limitsPrice
Cochrane author accessNo subscription required while writing a Cochrane Review · Cochrane Reviews only; discounted subscription for non-Cochrane reviewsFree
Practice reviewdeleted after 30 days · no data export · one person per reviewFree
Academic£100.00 + VAT (EU & UK), annual subscription · Academic eligibility required£100 a year
Individual academic annual subscription£100.00 + VAT (EU & UK) · eligibility shown after login£100 a year
Standard rate£130.00 + VAT (EU & UK), annual subscription · Individual subscription · eligibility shown after login£130 a year
Individual standard annual subscription£130.00 + VAT (EU & UK) · individual subscription£130 a year
Organization subscriptionPricing starts at £560 for up to 8 users · price varies by organization type and number of seats£560
OrganizationPricing starts at £560 for up to 8 users · Organization pricing varies by organization type and seats · Contact required£560

The first 8 of 10 plans, as cochrane.org lists them, read 20 Oct 2026. The maker's own page has the final word. Every plan

Getting started

  1. Visit the RevMan website.
  2. Choose the free Cochrane author access, free practice review, or an individual annual subscription.
  3. For an individual paid subscription, select the student, academic, or standard plan; eligibility is shown after login.
  4. Use RevMan on Linux, macOS, web, or Windows with Chrome, Firefox, or a newer Edge version.

RevMan is Cochrane’s software for writing and analyzing systematic reviews. It suits students, academics and review teams who need structured methods and shared editing. Its integrated analysis and reporting are compelling, but practice-review restrictions and the lack of mobile support can rule it out for some workflows.

Overview

RevMan supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative and flexible reviews. It combines review writing, analysis and visualization, but does not provide a screening workflow. Choose it when your project needs a structured review workspace; look elsewhere if screening must be part of the same tool.

Key features

Authors can edit separate parts of a review simultaneously and see who else is working on it. Ready-made or custom templates, structured headings and Cochrane methodological guidance give collaborators a shared framework. This is useful for teams coordinating a substantial review, though it does not replace a screening tool.

For quantitative work, RevMan supports pairwise meta-analyses, sensitivity and subgroup analyses, and fixed-effects, random-effects, Mantel-Haenszel and inverse-variance models. Built-in forest, SROC and funnel plots, risk-of-bias assessments and PRISMA flow diagrams connect analysis with reporting. That breadth is a strength for reviews needing these methods and outputs, but may be unnecessary for projects focused only on literature discovery or screening.

Study data and references can be imported from Covidence. RIS imports can draw on Crossref, PubMed or CRS. GRADEpro integration is not enabled for non-Cochrane reviews, and Cochrane Library data cannot be downloaded and reused in RevMan; those restrictions matter to authors planning around either workflow.

RevMan Web complies with GDPR for processing personal data of people in the EU, encrypts stored data and uses 256-bit SSL for communications. It is hosted on AWS, with customer data in London and Ireland, and uses Cochrane Account single sign-on with OpenID Connect. After a subscription ends, reviews and their history remain accessible in RevMan for 60 days, so subscribers should plan exports and continuity around that window.

Pricing

RevMan has a free practice-review plan, free Cochrane author access and paid individual and organization subscriptions. A 30-day trial is offered. The practice review costs nothing, but is limited to one person per review, has no data export and is deleted after 30 days. It is suitable for trying the workflow, not for retaining or collaborating on ongoing work.

Cochrane authors working on Cochrane Reviews get free access to RevMan Web. For individual paid use, the student subscription is £80 a year, billed £80.00 + VAT (EU & UK); eligibility is shown after login. The academic plan is £100 a year, billed £100.00 + VAT (EU & UK), with eligibility shown after login. The standard individual subscription is £130 a year, billed £130.00 + VAT (EU & UK). These annual plans suit individuals who need an ongoing review workspace; the lower student and academic prices depend on eligibility.

Organization subscriptions start at £560 for up to 8 users, with price varying by organization type and number of seats. This is the team option for organizations needing multiple accounts, but the starting price is not a fixed quote for every group. The cheaper practice plan gives up collaboration, retention and export, while Cochrane author access is limited to authors working on Cochrane Reviews.

Platforms

RevMan supports Linux, macOS, Windows and the web. RevMan Web supports Chrome, Firefox and newer Edge versions; mobile devices and touchscreen use are not supported. It is therefore a poor fit for reviewers who need to work from phones or tablets. The Knowledge Base directs users who need more help to contact the Cochrane Support Team.

Who it's for

RevMan is best suited to review authors who need structured writing, supported meta-analysis methods and report-ready visualizations, especially when collaborators need to work in parallel. Students and academics may fit the lower-priced individual plans if eligible; organizations can choose a subscription starting at £560 for up to 8 users. It is not the right choice for teams seeking an integrated screening workflow or mobile use.

Pros and cons

  • Pros: A broad set of review types and meta-analysis methods supports more than intervention reviews alone.
  • Pros: Shared editing, templates and methodological guidance give collaborators a common writing structure.
  • Pros: Built-in plots, risk-of-bias assessments and PRISMA flow diagrams bring analysis and reporting into one workspace.
  • Cons: The practice plan allows only one person per review, deletes work after 30 days and provides no export.
  • Cons: There is no screening workflow, and mobile devices and touchscreen use are unsupported.
  • Cons: GRADEpro integration is unavailable for non-Cochrane reviews, and Cochrane Library data cannot be reused in RevMan.

Alternatives

For a free, open-source review tool, ASReview may suit readers who can run it on their own hardware or server; those costs may still apply. Bibliometrix is a free open-source R package with a Biblioshiny web interface, a different option for readers who want that package-based approach.

EviSynth offers free academic access with unlimited collaborators and no subscription. Rayyan may fit teams centered on screening: its free plan allows 3 active reviews and 2 free reviewers, with limited mobile app access.

Elicit is another freemium option for readers seeking research-agent or research-report workflows, with limited usage on its Basic plan. Litmaps has a free plan for basic search, up to 20 inputs and 100 articles, but limits users to one Litmap and offers no collaboration on that plan.

ResearchRabbit may suit readers who want unlimited searches across 310+ million articles and shared collections on its free plan, which allows up to 50 seed articles. Abstrackr is a free option for readers prioritizing no seat limits or usage caps.

Browse Literature Review Software or Systematic Review Software for more options.

Verdict

Choose RevMan if you need a structured review-writing and analysis workspace with collaboration, supported meta-analysis methods and built-in reporting visuals. Its strongest advantage is bringing those review stages together; look elsewhere if you need screening, mobile access, or a practice plan that preserves and exports collaborative work.

Verdict

RevMan combines structured review writing, analysis, and visualization with collaboration tools. Check the practice-review restrictions and mobile limitations against your workflow before choosing a plan.

Questions

Is RevMan free?

RevMan offers free access for authors working on Cochrane Reviews and a free practice review. The practice review is deleted after 30 days, has no data export, and is limited to one person per review.

How much do individual subscriptions cost?

The listed annual prices are £80 for students, £100 for academics, and £130 for standard users. VAT applies to EU and UK customers, and eligibility for student and academic plans is shown after login.

Which platforms does RevMan support?

RevMan is available on Linux, macOS, web, and Windows. Mobile devices and touchscreen use are not supported.

What integrations does RevMan offer?

RevMan can import study data and references from Covidence. RIS reference imports can use data from Crossref, PubMed, or CRS; GRADEpro integration is not enabled for non-Cochrane reviews.

Who makes RevMan?

RevMan is distributed and sold by The Cochrane Collaboration, a registered charity and company limited by guarantee in England and Wales.

Facts from RevMan's own pages

API
Cochrane documents Review Document, ReviewDB and Group APIs, including a REST ReviewDB endpoint at api.cochrane.org. · documentation.cochrane.org, 20 Oct 2026
API extensibility
Technical documentation describes analysis endpoints and an independent NPM package for analysis JavaScript used by RevMan Web and its backend. · documentation.cochrane.org, 20 Oct 2026
Charts and diagrams
RevMan produces forest, SROC and funnel plots, risk-of-bias displays and PRISMA flow diagrams. · cochrane.org, 20 Oct 2026
Collaboration
Authors can edit different review fields concurrently and see which collaborators are currently working in a review. · documentation.cochrane.org, 20 Oct 2026
Company legal identity
RevMan is sold by The Cochrane Collaboration, an England-and-Wales company limited by guarantee and registered charity number 1045921, company number 03044323. · revman.cochrane.org, 20 Oct 2026
Covidence integration
RevMan imports citations and study data from Covidence and can reformat imported references. · cochrane.org, 20 Oct 2026
CRS integration
The roadmap lists easier study-reference import through Cochrane Register of Studies integration. · cochrane.org, 20 Oct 2026
Data retention
After a subscription ends, subscribers can access reviews and their history in RevMan for 60 days. · subscribe.cochrane.org, 2 Oct 2026
Documentation
The Knowledge Base covers data workflow, analyses, text editing, exporting, validation, version comparison, publishing, portfolio and administration. · documentation.cochrane.org, 20 Oct 2026
Effect measures
Built-in calculations include odds ratio, relative risk, relative difference, mean difference and standardized mean difference. · cochrane.org, 20 Oct 2026
File format
RevMan 5 stores reviews in structured RM5 XML files with hierarchical sections for electronic publication. · pmc.ncbi.nlm.nih.gov, 20 Oct 2026
GRADEpro limitation
GRADEpro GDT integration is available for Cochrane reviews but is not enabled for non-Cochrane individual reviews. · documentation.cochrane.org, 20 Oct 2026
Headquarters
London, United Kingdom · cochrane.org, 28 Sept 2026
Hosting and access
RevMan Web is hosted on AWS, uses Cochrane Account single sign-on with OpenID Connect, and AWS-hosted customer data is in London and Ireland. · subscribe.cochrane.org, 2 Oct 2026
Independent usability result
A comparative study of meta-analysis software measured RevMan's overall usability at 6.1 out of 10, with data preparation scoring 4.5 out of 10. · pmc.ncbi.nlm.nih.gov, 20 Oct 2026
Integration limit
GRADEpro integration is not enabled for non-Cochrane reviews, and Cochrane Library data cannot be downloaded and reused in RevMan. · documentation.cochrane.org, 2 Oct 2026
Integrations
RevMan can import study data and references from Covidence, and RIS reference imports can use data from Crossref, PubMed, or CRS. · documentation.cochrane.org, 2 Oct 2026
Intended users
RevMan supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. · documentation.cochrane.org, 2 Oct 2026
Legacy API status
The older RevManService SOAP API is largely stubbed because functionality moved to ReviewDB after RevMan 5.4. · documentation.cochrane.org, 20 Oct 2026
Limit: confusing UX
The independent interview study recorded user confusion with parts of RevMan's interface and workflow. · researchgate.net, 20 Oct 2026
Limit: data-set creation
The same study identified difficulty creating data sets as a recurring usability problem. · pmc.ncbi.nlm.nih.gov, 20 Oct 2026
Limit: language support
That analysis also noted that RevMan lacked built-in functionality for repeating findings in languages other than English. · pmc.ncbi.nlm.nih.gov, 20 Oct 2026
Limit: repetitive writing
A peer-reviewed analysis noted that transferring calculated table data into narrative text remains largely manual and prone to mistakes. · pmc.ncbi.nlm.nih.gov, 20 Oct 2026
Limit: restricted features
Interview participants reported that some RevMan capabilities were inaccessible unless a review was commissioned by Cochrane. · researchgate.net, 20 Oct 2026

Where RevMan stands on Freedom251

Look at these too